Old Web
Complement inhibitor for therapy of CHAPLE
2021
A new study shows successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
12
References
1
Citations
NaN
KQI